[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global In Vitro Screening Market 2022 by Company, Regions, Type and Application, Forecast to 2028

September 2022 | 110 pages | ID: GE159AE99144EN
GlobalInfoResearch

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The In Vitro Screening market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our (Global Info Research) latest study, due to COVID-19 and Russia-Ukraine War influence, the global In Vitro Screening market size was valued at USD million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period.

The In Vitro Screening market in the USA. is estimated at USD million in 2022, which currently accounts for a % share in the global market. China, the world`s second largest economy, is estimated at USD million in 2022 and holds a % percent.

Oncology occupied for % of the In Vitro Screening global market in 2021, and it is projected to value USD million by 2028, growing at a % CAGR in next six years. In terms of product type, Enzymes segment is altered to a % CAGR between 2022 and 2028.

Global key companies of In Vitro Screening include Thermo Fisher Scientific, PerkinElmer, Merck, Charles River and Pharmaron, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Key Features of This Report:

This report provides in-depth analysis of the global In Vitro Screening market, and provides market size and CAGR for the history and forecast period (2017-2022, 2023-2028), considering 2021 as the base year.

Main In Vitro Screening companies’ industry ranking, revenue, and market share analysis. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This reports profiles key players in the global In Vitro Screening market based on the following parameters – headquarters, products portfolio, In Vitro Screening revenue and gross margin, recent developments.

Evaluation and forecast the In Vitro Screening market size, projected growth trends, and corresponding market share analysis by type, by application and by region. It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

Highlights of the current market scenario, recent information, latest developments, and factors impacting the growth of the market

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Market segmentation

In Vitro Screening market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of revenue. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type (2017-2028; USD Million)
  • Enzymes
  • Ion Channels
  • GPCRs
  • Nuclear Receptors
  • Protein-protein Interactions
Market segment by Application (2017-2028; USD Million)
  • Oncology
  • Immunology
  • Metabolic Diseases
  • CNS
  • Others
The key market players for global In Vitro Screening market are listed below:
  • Thermo Fisher Scientific
  • PerkinElmer
  • Merck
  • Charles River
  • Pharmaron
  • Reaction Biology
  • Eurofins Discovery
  • Frontage Laboratories
  • Atlantic Bone Screen
  • Intertek
  • Visikol
  • Evotec
  • Tergus Pharma
  • QIMA Life Sciences
  • Wuxi Biortus Biosciences
  • ICE Bioscience
  • Viva Biotech
  • Topscience
Region Segment (2017-2028; USD Million)
  • North America (United States, Canada, and Mexico)
  • Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Australia)
  • South America (Brazil, Argentina, Colombia and Rest of South America)
  • Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe In Vitro Screening product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of In Vitro Screening, with revenue, gross margin and global market share of In Vitro Screening from 2019 to 2022.

Chapter 3, the In Vitro Screening competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and In Vitro Screening market forecast, by regions, type and application, with revenue, from 2023 to 2028.

Chapter 11 and 12, to describe In Vitro Screening research findings and conclusion, appendix and data source.
1 MARKET OVERVIEW

1.1 Product Overview and Scope of In Vitro Screening
1.2 Classification of In Vitro Screening by Type
  1.2.1 Overview: Global In Vitro Screening Market Size by Type: 2017 Versus 2021 Versus 2028
  1.2.2 Global In Vitro Screening Revenue Market Share by Type in 2021
  1.2.3 Enzymes
  1.2.4 Ion Channels
  1.2.5 GPCRs
  1.2.6 Nuclear Receptors
  1.2.7 Protein-protein Interactions
1.3 Global In Vitro Screening Market by Application
  1.3.1 Overview: Global In Vitro Screening Market Size by Application: 2017 Versus 2021 Versus 2028
  1.3.2 Oncology
  1.3.3 Immunology
  1.3.4 Metabolic Diseases
  1.3.5 CNS
  1.3.6 Others
1.4 Global In Vitro Screening Market Size & Forecast
1.5 Global In Vitro Screening Market Size and Forecast by Region
  1.5.1 Global In Vitro Screening Market Size by Region: 2017 VS 2021 VS 2028
  1.5.2 Global In Vitro Screening Market Size by Region, (2017-2022)
  1.5.3 North America In Vitro Screening Market Size and Prospect (2017-2028)
  1.5.4 Europe In Vitro Screening Market Size and Prospect (2017-2028)
  1.5.5 Asia-Pacific In Vitro Screening Market Size and Prospect (2017-2028)
  1.5.6 South America In Vitro Screening Market Size and Prospect (2017-2028)
  1.5.7 Middle East and Africa In Vitro Screening Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
  1.6.1 In Vitro Screening Market Drivers
  1.6.2 In Vitro Screening Market Restraints
  1.6.3 In Vitro Screening Trends Analysis

2 COMPANY PROFILES

2.1 Thermo Fisher Scientific
  2.1.1 Thermo Fisher Scientific Details
  2.1.2 Thermo Fisher Scientific Major Business
  2.1.3 Thermo Fisher Scientific In Vitro Screening Product and Solutions
  2.1.4 Thermo Fisher Scientific In Vitro Screening Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.1.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.2 PerkinElmer
  2.2.1 PerkinElmer Details
  2.2.2 PerkinElmer Major Business
  2.2.3 PerkinElmer In Vitro Screening Product and Solutions
  2.2.4 PerkinElmer In Vitro Screening Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.2.5 PerkinElmer Recent Developments and Future Plans
2.3 Merck
  2.3.1 Merck Details
  2.3.2 Merck Major Business
  2.3.3 Merck In Vitro Screening Product and Solutions
  2.3.4 Merck In Vitro Screening Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.3.5 Merck Recent Developments and Future Plans
2.4 Charles River
  2.4.1 Charles River Details
  2.4.2 Charles River Major Business
  2.4.3 Charles River In Vitro Screening Product and Solutions
  2.4.4 Charles River In Vitro Screening Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.4.5 Charles River Recent Developments and Future Plans
2.5 Pharmaron
  2.5.1 Pharmaron Details
  2.5.2 Pharmaron Major Business
  2.5.3 Pharmaron In Vitro Screening Product and Solutions
  2.5.4 Pharmaron In Vitro Screening Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.5.5 Pharmaron Recent Developments and Future Plans
2.6 Reaction Biology
  2.6.1 Reaction Biology Details
  2.6.2 Reaction Biology Major Business
  2.6.3 Reaction Biology In Vitro Screening Product and Solutions
  2.6.4 Reaction Biology In Vitro Screening Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.6.5 Reaction Biology Recent Developments and Future Plans
2.7 Eurofins Discovery
  2.7.1 Eurofins Discovery Details
  2.7.2 Eurofins Discovery Major Business
  2.7.3 Eurofins Discovery In Vitro Screening Product and Solutions
  2.7.4 Eurofins Discovery In Vitro Screening Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.7.5 Eurofins Discovery Recent Developments and Future Plans
2.8 Frontage Laboratories
  2.8.1 Frontage Laboratories Details
  2.8.2 Frontage Laboratories Major Business
  2.8.3 Frontage Laboratories In Vitro Screening Product and Solutions
  2.8.4 Frontage Laboratories In Vitro Screening Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.8.5 Frontage Laboratories Recent Developments and Future Plans
2.9 Atlantic Bone Screen
  2.9.1 Atlantic Bone Screen Details
  2.9.2 Atlantic Bone Screen Major Business
  2.9.3 Atlantic Bone Screen In Vitro Screening Product and Solutions
  2.9.4 Atlantic Bone Screen In Vitro Screening Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.9.5 Atlantic Bone Screen Recent Developments and Future Plans
2.10 Intertek
  2.10.1 Intertek Details
  2.10.2 Intertek Major Business
  2.10.3 Intertek In Vitro Screening Product and Solutions
  2.10.4 Intertek In Vitro Screening Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.10.5 Intertek Recent Developments and Future Plans
2.11 Visikol
  2.11.1 Visikol Details
  2.11.2 Visikol Major Business
  2.11.3 Visikol In Vitro Screening Product and Solutions
  2.11.4 Visikol In Vitro Screening Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.11.5 Visikol Recent Developments and Future Plans
2.12 Evotec
  2.12.1 Evotec Details
  2.12.2 Evotec Major Business
  2.12.3 Evotec In Vitro Screening Product and Solutions
  2.12.4 Evotec In Vitro Screening Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.12.5 Evotec Recent Developments and Future Plans
2.13 Tergus Pharma
  2.13.1 Tergus Pharma Details
  2.13.2 Tergus Pharma Major Business
  2.13.3 Tergus Pharma In Vitro Screening Product and Solutions
  2.13.4 Tergus Pharma In Vitro Screening Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.13.5 Tergus Pharma Recent Developments and Future Plans
2.14 QIMA Life Sciences
  2.14.1 QIMA Life Sciences Details
  2.14.2 QIMA Life Sciences Major Business
  2.14.3 QIMA Life Sciences In Vitro Screening Product and Solutions
  2.14.4 QIMA Life Sciences In Vitro Screening Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.14.5 QIMA Life Sciences Recent Developments and Future Plans
2.15 Wuxi Biortus Biosciences
  2.15.1 Wuxi Biortus Biosciences Details
  2.15.2 Wuxi Biortus Biosciences Major Business
  2.15.3 Wuxi Biortus Biosciences In Vitro Screening Product and Solutions
  2.15.4 Wuxi Biortus Biosciences In Vitro Screening Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.15.5 Wuxi Biortus Biosciences Recent Developments and Future Plans
2.16 ICE Bioscience
  2.16.1 ICE Bioscience Details
  2.16.2 ICE Bioscience Major Business
  2.16.3 ICE Bioscience In Vitro Screening Product and Solutions
  2.16.4 ICE Bioscience In Vitro Screening Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.16.5 ICE Bioscience Recent Developments and Future Plans
2.17 Viva Biotech
  2.17.1 Viva Biotech Details
  2.17.2 Viva Biotech Major Business
  2.17.3 Viva Biotech In Vitro Screening Product and Solutions
  2.17.4 Viva Biotech In Vitro Screening Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.17.5 Viva Biotech Recent Developments and Future Plans
2.18 Topscience
  2.18.1 Topscience Details
  2.18.2 Topscience Major Business
  2.18.3 Topscience In Vitro Screening Product and Solutions
  2.18.4 Topscience In Vitro Screening Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.18.5 Topscience Recent Developments and Future Plans

3 MARKET COMPETITION, BY PLAYERS

3.1 Global In Vitro Screening Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
  3.2.1 Top 3 In Vitro Screening Players Market Share in 2021
  3.2.2 Top 10 In Vitro Screening Players Market Share in 2021
  3.2.3 Market Competition Trend
3.3 In Vitro Screening Players Head Office, Products and Services Provided
3.4 In Vitro Screening Mergers & Acquisitions
3.5 In Vitro Screening New Entrants and Expansion Plans

4 MARKET SIZE SEGMENT BY TYPE

4.1 Global In Vitro Screening Revenue and Market Share by Type (2017-2022)
4.2 Global In Vitro Screening Market Forecast by Type (2023-2028)

5 MARKET SIZE SEGMENT BY APPLICATION

5.1 Global In Vitro Screening Revenue Market Share by Application (2017-2022)
5.2 Global In Vitro Screening Market Forecast by Application (2023-2028)

6 NORTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION

6.1 North America In Vitro Screening Revenue by Type (2017-2028)
6.2 North America In Vitro Screening Revenue by Application (2017-2028)
6.3 North America In Vitro Screening Market Size by Country
  6.3.1 North America In Vitro Screening Revenue by Country (2017-2028)
  6.3.2 United States In Vitro Screening Market Size and Forecast (2017-2028)
  6.3.3 Canada In Vitro Screening Market Size and Forecast (2017-2028)
  6.3.4 Mexico In Vitro Screening Market Size and Forecast (2017-2028)

7 EUROPE BY COUNTRY, BY TYPE, AND BY APPLICATION

7.1 Europe In Vitro Screening Revenue by Type (2017-2028)
7.2 Europe In Vitro Screening Revenue by Application (2017-2028)
7.3 Europe In Vitro Screening Market Size by Country
  7.3.1 Europe In Vitro Screening Revenue by Country (2017-2028)
  7.3.2 Germany In Vitro Screening Market Size and Forecast (2017-2028)
  7.3.3 France In Vitro Screening Market Size and Forecast (2017-2028)
  7.3.4 United Kingdom In Vitro Screening Market Size and Forecast (2017-2028)
  7.3.5 Russia In Vitro Screening Market Size and Forecast (2017-2028)
  7.3.6 Italy In Vitro Screening Market Size and Forecast (2017-2028)

8 ASIA-PACIFIC BY REGION, BY TYPE, AND BY APPLICATION

8.1 Asia-Pacific In Vitro Screening Revenue by Type (2017-2028)
8.2 Asia-Pacific In Vitro Screening Revenue by Application (2017-2028)
8.3 Asia-Pacific In Vitro Screening Market Size by Region
  8.3.1 Asia-Pacific In Vitro Screening Revenue by Region (2017-2028)
  8.3.2 China In Vitro Screening Market Size and Forecast (2017-2028)
  8.3.3 Japan In Vitro Screening Market Size and Forecast (2017-2028)
  8.3.4 South Korea In Vitro Screening Market Size and Forecast (2017-2028)
  8.3.5 India In Vitro Screening Market Size and Forecast (2017-2028)
  8.3.6 Southeast Asia In Vitro Screening Market Size and Forecast (2017-2028)
  8.3.7 Australia In Vitro Screening Market Size and Forecast (2017-2028)

9 SOUTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION

9.1 South America In Vitro Screening Revenue by Type (2017-2028)
9.2 South America In Vitro Screening Revenue by Application (2017-2028)
9.3 South America In Vitro Screening Market Size by Country
  9.3.1 South America In Vitro Screening Revenue by Country (2017-2028)
  9.3.2 Brazil In Vitro Screening Market Size and Forecast (2017-2028)
  9.3.3 Argentina In Vitro Screening Market Size and Forecast (2017-2028)

10 MIDDLE EAST & AFRICA BY COUNTRY, BY TYPE, AND BY APPLICATION

10.1 Middle East & Africa In Vitro Screening Revenue by Type (2017-2028)
10.2 Middle East & Africa In Vitro Screening Revenue by Application (2017-2028)
10.3 Middle East & Africa In Vitro Screening Market Size by Country
  10.3.1 Middle East & Africa In Vitro Screening Revenue by Country (2017-2028)
  10.3.2 Turkey In Vitro Screening Market Size and Forecast (2017-2028)
  10.3.3 Saudi Arabia In Vitro Screening Market Size and Forecast (2017-2028)
  10.3.4 UAE In Vitro Screening Market Size and Forecast (2017-2028)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

LIST OF TABLES

Table 1. Global In Vitro Screening Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global In Vitro Screening Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market In Vitro Screening Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global In Vitro Screening Revenue (USD Million) by Region (2017-2022)
Table 5. Global In Vitro Screening Revenue Market Share by Region (2023-2028)
Table 6. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors
Table 7. Thermo Fisher Scientific Major Business
Table 8. Thermo Fisher Scientific In Vitro Screening Product and Solutions
Table 9. Thermo Fisher Scientific In Vitro Screening Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. PerkinElmer Corporate Information, Head Office, and Major Competitors
Table 11. PerkinElmer Major Business
Table 12. PerkinElmer In Vitro Screening Product and Solutions
Table 13. PerkinElmer In Vitro Screening Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Merck Corporate Information, Head Office, and Major Competitors
Table 15. Merck Major Business
Table 16. Merck In Vitro Screening Product and Solutions
Table 17. Merck In Vitro Screening Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Charles River Corporate Information, Head Office, and Major Competitors
Table 19. Charles River Major Business
Table 20. Charles River In Vitro Screening Product and Solutions
Table 21. Charles River In Vitro Screening Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Pharmaron Corporate Information, Head Office, and Major Competitors
Table 23. Pharmaron Major Business
Table 24. Pharmaron In Vitro Screening Product and Solutions
Table 25. Pharmaron In Vitro Screening Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Reaction Biology Corporate Information, Head Office, and Major Competitors
Table 27. Reaction Biology Major Business
Table 28. Reaction Biology In Vitro Screening Product and Solutions
Table 29. Reaction Biology In Vitro Screening Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Eurofins Discovery Corporate Information, Head Office, and Major Competitors
Table 31. Eurofins Discovery Major Business
Table 32. Eurofins Discovery In Vitro Screening Product and Solutions
Table 33. Eurofins Discovery In Vitro Screening Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Frontage Laboratories Corporate Information, Head Office, and Major Competitors
Table 35. Frontage Laboratories Major Business
Table 36. Frontage Laboratories In Vitro Screening Product and Solutions
Table 37. Frontage Laboratories In Vitro Screening Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Atlantic Bone Screen Corporate Information, Head Office, and Major Competitors
Table 39. Atlantic Bone Screen Major Business
Table 40. Atlantic Bone Screen In Vitro Screening Product and Solutions
Table 41. Atlantic Bone Screen In Vitro Screening Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Intertek Corporate Information, Head Office, and Major Competitors
Table 43. Intertek Major Business
Table 44. Intertek In Vitro Screening Product and Solutions
Table 45. Intertek In Vitro Screening Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Visikol Corporate Information, Head Office, and Major Competitors
Table 47. Visikol Major Business
Table 48. Visikol In Vitro Screening Product and Solutions
Table 49. Visikol In Vitro Screening Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Evotec Corporate Information, Head Office, and Major Competitors
Table 51. Evotec Major Business
Table 52. Evotec In Vitro Screening Product and Solutions
Table 53. Evotec In Vitro Screening Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Tergus Pharma Corporate Information, Head Office, and Major Competitors
Table 55. Tergus Pharma Major Business
Table 56. Tergus Pharma In Vitro Screening Product and Solutions
Table 57. Tergus Pharma In Vitro Screening Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. QIMA Life Sciences Corporate Information, Head Office, and Major Competitors
Table 59. QIMA Life Sciences Major Business
Table 60. QIMA Life Sciences In Vitro Screening Product and Solutions
Table 61. QIMA Life Sciences In Vitro Screening Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. Wuxi Biortus Biosciences Corporate Information, Head Office, and Major Competitors
Table 63. Wuxi Biortus Biosciences Major Business
Table 64. Wuxi Biortus Biosciences In Vitro Screening Product and Solutions
Table 65. Wuxi Biortus Biosciences In Vitro Screening Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 66. ICE Bioscience Corporate Information, Head Office, and Major Competitors
Table 67. ICE Bioscience Major Business
Table 68. ICE Bioscience In Vitro Screening Product and Solutions
Table 69. ICE Bioscience In Vitro Screening Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 70. Viva Biotech Corporate Information, Head Office, and Major Competitors
Table 71. Viva Biotech Major Business
Table 72. Viva Biotech In Vitro Screening Product and Solutions
Table 73. Viva Biotech In Vitro Screening Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 74. Topscience Corporate Information, Head Office, and Major Competitors
Table 75. Topscience Major Business
Table 76. Topscience In Vitro Screening Product and Solutions
Table 77. Topscience In Vitro Screening Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 78. Global In Vitro Screening Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 79. Global In Vitro Screening Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 80. Breakdown of In Vitro Screening by Company Type (Tier 1, Tier 2 and Tier 3)
Table 81. In Vitro Screening Players Head Office, Products and Services Provided
Table 82. In Vitro Screening Mergers & Acquisitions in the Past Five Years
Table 83. In Vitro Screening New Entrants and Expansion Plans
Table 84. Global In Vitro Screening Revenue (USD Million) by Type (2017-2022)
Table 85. Global In Vitro Screening Revenue Share by Type (2017-2022)
Table 86. Global In Vitro Screening Revenue Forecast by Type (2023-2028)
Table 87. Global In Vitro Screening Revenue by Application (2017-2022)
Table 88. Global In Vitro Screening Revenue Forecast by Application (2023-2028)
Table 89. North America In Vitro Screening Revenue by Type (2017-2022) & (USD Million)
Table 90. North America In Vitro Screening Revenue by Type (2023-2028) & (USD Million)
Table 91. North America In Vitro Screening Revenue by Application (2017-2022) & (USD Million)
Table 92. North America In Vitro Screening Revenue by Application (2023-2028) & (USD Million)
Table 93. North America In Vitro Screening Revenue by Country (2017-2022) & (USD Million)
Table 94. North America In Vitro Screening Revenue by Country (2023-2028) & (USD Million)
Table 95. Europe In Vitro Screening Revenue by Type (2017-2022) & (USD Million)
Table 96. Europe In Vitro Screening Revenue by Type (2023-2028) & (USD Million)
Table 97. Europe In Vitro Screening Revenue by Application (2017-2022) & (USD Million)
Table 98. Europe In Vitro Screening Revenue by Application (2023-2028) & (USD Million)
Table 99. Europe In Vitro Screening Revenue by Country (2017-2022) & (USD Million)
Table 100. Europe In Vitro Screening Revenue by Country (2023-2028) & (USD Million)
Table 101. Asia-Pacific In Vitro Screening Revenue by Type (2017-2022) & (USD Million)
Table 102. Asia-Pacific In Vitro Screening Revenue by Type (2023-2028) & (USD Million)
Table 103. Asia-Pacific In Vitro Screening Revenue by Application (2017-2022) & (USD Million)
Table 104. Asia-Pacific In Vitro Screening Revenue by Application (2023-2028) & (USD Million)
Table 105. Asia-Pacific In Vitro Screening Revenue by Region (2017-2022) & (USD Million)
Table 106. Asia-Pacific In Vitro Screening Revenue by Region (2023-2028) & (USD Million)
Table 107. South America In Vitro Screening Revenue by Type (2017-2022) & (USD Million)
Table 108. South America In Vitro Screening Revenue by Type (2023-2028) & (USD Million)
Table 109. South America In Vitro Screening Revenue by Application (2017-2022) & (USD Million)
Table 110. South America In Vitro Screening Revenue by Application (2023-2028) & (USD Million)
Table 111. South America In Vitro Screening Revenue by Country (2017-2022) & (USD Million)
Table 112. South America In Vitro Screening Revenue by Country (2023-2028) & (USD Million)
Table 113. Middle East & Africa In Vitro Screening Revenue by Type (2017-2022) & (USD Million)
Table 114. Middle East & Africa In Vitro Screening Revenue by Type (2023-2028) & (USD Million)
Table 115. Middle East & Africa In Vitro Screening Revenue by Application (2017-2022) & (USD Million)
Table 116. Middle East & Africa In Vitro Screening Revenue by Application (2023-2028) & (USD Million)
Table 117. Middle East & Africa In Vitro Screening Revenue by Country (2017-2022) & (USD Million)
Table 118. Middle East & Africa In Vitro Screening Revenue by Country (2023-2028) & (USD Million)

LIST OF FIGURES

Figure 1. In Vitro Screening Picture
Figure 2. Global In Vitro Screening Revenue Market Share by Type in 2021
Figure 3. Enzymes
Figure 4. Ion Channels
Figure 5. GPCRs
Figure 6. Nuclear Receptors
Figure 7. Protein-protein Interactions
Figure 8. In Vitro Screening Revenue Market Share by Application in 2021
Figure 9. Oncology Picture
Figure 10. Immunology Picture
Figure 11. Metabolic Diseases Picture
Figure 12. CNS Picture
Figure 13. Others Picture
Figure 14. Global In Vitro Screening Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 15. Global In Vitro Screening Revenue and Forecast (2017-2028) & (USD Million)
Figure 16. Global In Vitro Screening Revenue Market Share by Region (2017-2028)
Figure 17. Global In Vitro Screening Revenue Market Share by Region in 2021
Figure 18. North America In Vitro Screening Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Europe In Vitro Screening Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Asia-Pacific In Vitro Screening Revenue (USD Million) and Growth Rate (2017-2028)
Figure 21. South America In Vitro Screening Revenue (USD Million) and Growth Rate (2017-2028)
Figure 22. Middle East and Africa In Vitro Screening Revenue (USD Million) and Growth Rate (2017-2028)
Figure 23. In Vitro Screening Market Drivers
Figure 24. In Vitro Screening Market Restraints
Figure 25. In Vitro Screening Market Trends
Figure 26. Thermo Fisher Scientific Recent Developments and Future Plans
Figure 27. PerkinElmer Recent Developments and Future Plans
Figure 28. Merck Recent Developments and Future Plans
Figure 29. Charles River Recent Developments and Future Plans
Figure 30. Pharmaron Recent Developments and Future Plans
Figure 31. Reaction Biology Recent Developments and Future Plans
Figure 32. Eurofins Discovery Recent Developments and Future Plans
Figure 33. Frontage Laboratories Recent Developments and Future Plans
Figure 34. Atlantic Bone Screen Recent Developments and Future Plans
Figure 35. Intertek Recent Developments and Future Plans
Figure 36. Visikol Recent Developments and Future Plans
Figure 37. Evotec Recent Developments and Future Plans
Figure 38. Tergus Pharma Recent Developments and Future Plans
Figure 39. QIMA Life Sciences Recent Developments and Future Plans
Figure 40. Wuxi Biortus Biosciences Recent Developments and Future Plans
Figure 41. ICE Bioscience Recent Developments and Future Plans
Figure 42. Viva Biotech Recent Developments and Future Plans
Figure 43. Topscience Recent Developments and Future Plans
Figure 44. Global In Vitro Screening Revenue Share by Players in 2021
Figure 45. In Vitro Screening Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 46. Global Top 3 Players In Vitro Screening Revenue Market Share in 2021
Figure 47. Global Top 10 Players In Vitro Screening Revenue Market Share in 2021
Figure 48. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 49. Global In Vitro Screening Revenue Share by Type in 2021
Figure 50. Global In Vitro Screening Market Share Forecast by Type (2023-2028)
Figure 51. Global In Vitro Screening Revenue Share by Application in 2021
Figure 52. Global In Vitro Screening Market Share Forecast by Application (2023-2028)
Figure 53. North America In Vitro Screening Sales Market Share by Type (2017-2028)
Figure 54. North America In Vitro Screening Sales Market Share by Application (2017-2028)
Figure 55. North America In Vitro Screening Revenue Market Share by Country (2017-2028)
Figure 56. United States In Vitro Screening Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Canada In Vitro Screening Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Mexico In Vitro Screening Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Europe In Vitro Screening Sales Market Share by Type (2017-2028)
Figure 60. Europe In Vitro Screening Sales Market Share by Application (2017-2028)
Figure 61. Europe In Vitro Screening Revenue Market Share by Country (2017-2028)
Figure 62. Germany In Vitro Screening Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. France In Vitro Screening Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. United Kingdom In Vitro Screening Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Russia In Vitro Screening Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Italy In Vitro Screening Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Asia-Pacific In Vitro Screening Sales Market Share by Type (2017-2028)
Figure 68. Asia-Pacific In Vitro Screening Sales Market Share by Application (2017-2028)
Figure 69. Asia-Pacific In Vitro Screening Revenue Market Share by Region (2017-2028)
Figure 70. China In Vitro Screening Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Japan In Vitro Screening Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. South Korea In Vitro Screening Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. India In Vitro Screening Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Southeast Asia In Vitro Screening Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Australia In Vitro Screening Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. South America In Vitro Screening Sales Market Share by Type (2017-2028)
Figure 77. South America In Vitro Screening Sales Market Share by Application (2017-2028)
Figure 78. South America In Vitro Screening Revenue Market Share by Country (2017-2028)
Figure 79. Brazil In Vitro Screening Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Argentina In Vitro Screening Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. Middle East and Africa In Vitro Screening Sales Market Share by Type (2017-2028)
Figure 82. Middle East and Africa In Vitro Screening Sales Market Share by Application (2017-2028)
Figure 83. Middle East and Africa In Vitro Screening Revenue Market Share by Country (2017-2028)
Figure 84. Turkey In Vitro Screening Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 85. Saudi Arabia In Vitro Screening Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 86. UAE In Vitro Screening Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 87. Methodology
Figure 88. Research Process and Data Source


More Publications